======= PTPN14 ======= == Gene Information == * **Official Symbol**: PTPN14 * **Official Name**: protein tyrosine phosphatase non-receptor type 14 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=5784|5784]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q15678|Q15678]] * **Interactions**: [[https://thebiogrid.org/search.php?search=PTPN14&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PTPN14|Open PubMed]] * **OMIM**: [[https://omim.org/entry/603155|Open OMIM]] == Function Summary == * **Entrez Summary**: The protein encoded by this gene is a member of the protein tyrosine phosphatase (PTP) family. PTPs are known to be signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This PTP contains an N-terminal noncatalytic domain similar to that of band 4.1 superfamily cytoskeleton-associated proteins, which suggested the membrane or cytoskeleton localization of this protein. It appears to regulate lymphatic development in mammals, and a loss of function mutation has been found in a kindred with a lymphedema-choanal atresia. [provided by RefSeq, Sep 2010]. * **UniProt Summary**: Protein tyrosine phosphatase which may play a role in the regulation of lymphangiogenesis, cell-cell adhesion, cell- matrix adhesion, cell migration, cell growth and also regulates TGF-beta gene expression, thereby modulating epithelial- mesenchymal transition. Mediates beta-catenin dephosphorylation at adhesion junctions. Acts as a negative regulator of the oncogenic property of YAP, a downstream target of the hippo pathway, in a cell density-dependent manner. May function as a tumor suppressor. {ECO:0000269|PubMed:10934049, ECO:0000269|PubMed:12808048, ECO:0000269|PubMed:17893246, ECO:0000269|PubMed:20826270, ECO:0000269|PubMed:22233626, ECO:0000269|PubMed:22525271, ECO:0000269|PubMed:22948661}. |FERM N| |Y phosphatase| |FERM M| |DSPc| |FERM C| |lymphangiogenesis| |lymph vessel morphogenesis| |lymph vessel development| |regulation of protein export from nucleus| |receptor tyrosine kinase binding| |transcription coregulator activity| |protein tyrosine phosphatase activity| |peptidyl-tyrosine dephosphorylation| |regulation of nucleocytoplasmic transport| |protein dephosphorylation| |regulation of intracellular protein transport| |dephosphorylation| |regulation of intracellular transport| |cytoskeleton| |vasculature development| |cardiovascular system development| |regulation of cellular protein localization| |negative regulation of cell population proliferation| |regulation of protein transport| |regulation of peptide transport| |regulation of establishment of protein localization| |circulatory system development| |anatomical structure formation involved in morphogenesis| |regulation of cellular localization| |cellular response to cytokine stimulus| |regulation of protein localization| |response to cytokine| |regulation of cell population proliferation| |regulation of transport| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp512|Olaparib 4μM R08 exp512]]|1.71| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 4165 * **Expression level (log2 read counts)**: 4.14 {{:chemogenomics:nalm6 dist.png?nolink |}}